CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT)
CUSIP: 218352102
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 106,815,676
- Total 13F shares
- 89,063,766
- Share change
- +4,008,302
- Total reported value
- $1,077,729,997
- Put/Call ratio
- 73%
- Price per share
- $12.10
- Number of holders
- 199
- Value change
- +$45,482,106
- Number of buys
- 103
- Number of sells
- 88
Quarterly Holders Quick Answers
What is CUSIP 218352102?
CUSIP 218352102 identifies CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 218352102:
Top shareholders of CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
15%
|
15,537,529
|
$219,625,000 | — | 30 Sep 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
10,906,661
|
$154,166,000 | — | 30 Sep 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
8.7%
|
9,241,700
|
$130,631,000 | — | 30 Sep 2019 | |
| INGALLS & SNYDER LLC |
13F
|
Company |
8.2%
|
8,712,176
|
$123,147,000 | — | 30 Sep 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
6.1%
|
6,524,209
|
$92,220,000 | — | 30 Sep 2019 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
2,915,521
|
$41,211,000 | — | 30 Sep 2019 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.4%
|
2,548,687
|
$36,027,000 | — | 30 Sep 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,416,399
|
$20,020,000 | — | 30 Sep 2019 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
1,415,512
|
$20,009,000 | — | 30 Sep 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
1,298,416
|
$18,354,000 | — | 30 Sep 2019 | |
| Parallel Advisors, LLC |
13F
|
Company |
1.2%
|
1,277,851
|
$18,062,000 | — | 30 Sep 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.1%
|
1,227,823
|
$17,356,000 | — | 30 Sep 2019 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
1%
|
1,089,386
|
$15,398,000 | — | 30 Sep 2019 | |
| NORGES BANK |
13F
|
Company |
0.99%
|
1,055,507
|
$14,920,000 | — | 30 Sep 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.94%
|
1,000,854
|
$14,146,000 | — | 30 Sep 2019 | |
| Matarin Capital Management, LLC |
13F
|
Company |
0.83%
|
891,636
|
$12,603,000 | — | 30 Sep 2019 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.77%
|
825,234
|
$11,664,000 | — | 30 Sep 2019 | |
| AMI ASSET MANAGEMENT CORP |
13F
|
Company |
0.73%
|
775,685
|
$10,964,000 | — | 30 Sep 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.67%
|
713,516
|
$10,085,000 | — | 30 Sep 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.67%
|
711,753
|
$10,060,000 | — | 30 Sep 2019 | |
| FMR LLC |
13F
|
Company |
0.66%
|
703,870
|
$9,949,000 | — | 30 Sep 2019 | |
| S&T BANK/PA |
13F
|
Company |
0.59%
|
625,078
|
$8,859,000 | — | 30 Sep 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.56%
|
600,355
|
$8,487,000 | — | 30 Sep 2019 | |
| AJ WEALTH STRATEGIES, LLC |
13F
|
Company |
0.56%
|
595,828
|
$8,422,000 | — | 30 Sep 2019 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.51%
|
543,275
|
$7,678,000 | — | 30 Sep 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.49%
|
518,158
|
$7,324,000 | — | 30 Sep 2019 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.36%
|
388,494
|
$5,491,000 | — | 30 Sep 2019 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.35%
|
376,733
|
$5,325,000 | — | 30 Sep 2019 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.28%
|
295,877
|
$4,314,000 | — | 30 Sep 2019 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.27%
|
290,186
|
$4,100,000 | — | 30 Sep 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.26%
|
282,325
|
$3,991,000 | — | 30 Sep 2019 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.26%
|
277,620
|
$3,924,000 | — | 30 Sep 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0.26%
|
275,820
|
$3,899,000 | — | 30 Sep 2019 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.24%
|
259,709
|
$3,671,000 | — | 30 Sep 2019 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.22%
|
237,987
|
$3,325,000 | — | 30 Sep 2019 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.22%
|
232,783
|
$3,290,000 | — | 30 Sep 2019 | |
| Man Group plc |
13F
|
Company |
0.21%
|
220,762
|
$3,120,000 | — | 30 Sep 2019 | |
| State of New Jersey Common Pension Fund D |
13F
|
Company |
0.2%
|
216,600
|
$3,062,000 | — | 30 Sep 2019 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.19%
|
208,039
|
$2,941,000 | — | 30 Sep 2019 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.19%
|
202,741
|
$2,866,000 | — | 30 Sep 2019 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.19%
|
201,718
|
$2,851,000 | — | 30 Sep 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.19%
|
199,400
|
$2,819,000 | — | 30 Sep 2019 | |
| Swiss National Bank |
13F
|
Company |
0.18%
|
193,900
|
$2,741,000 | — | 30 Sep 2019 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.18%
|
193,181
|
$2,729,000 | — | 30 Sep 2019 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.16%
|
175,362
|
$2,479,000 | — | 30 Sep 2019 | |
| QS Investors, LLC |
13F
|
Company |
0.16%
|
170,524
|
$2,411,000 | — | 30 Sep 2019 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.16%
|
168,857
|
$2,387,000 | — | 30 Sep 2019 | |
| Capital Impact Advisors, LLC |
13F
|
Company |
0.15%
|
162,544
|
$2,370,000 | — | 30 Sep 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.15%
|
157,111
|
$2,219,000 | — | 30 Sep 2019 | |
| UBS Group AG |
13F
|
Company |
0.14%
|
154,183
|
$2,179,000 | — | 30 Sep 2019 |
Institutional Holders of CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT) as of Q4 2019
As of 31 Dec 2019,
CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT) was held by
199 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,063,766 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, FEDERATED HERMES, INC., INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Invesco Ltd., LSV ASSET MANAGEMENT, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
199
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
190
Q4 2019 holders
199
Holder diff
9
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.